{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:15:55Z","timestamp":1783372555591,"version":"3.54.6"},"reference-count":56,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The tumor-host interaction in the tumor microenvironment (TME) affects the prognosis of patients with malignant tumors. TME assessed via tumor budding (BD) and tumor-infiltrating lymphocyte (TIL) had a prognostic impact in patients with nonampullary small intestinal and colorectal carcinomas. In ampullary carcinoma (AC), MUC5AC was recently revealed as a significant prognosticator, but studies about the TME have not been conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To assess TME-based prognostic risk in AC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We generated a collective TME risk index based on high-grade BD at the invasive front (BD3) and high density of stromal-TIL (&amp;gt;5%) in 64 surgically resected ACs. We evaluated its predictive values for overall survival (OS) and recurrence-free survival (RFS). We also investigated the relationship of TME to MUC5AC expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>TME prognostic risk index was classified into low-risk (BDLow\/TILHigh; 26 of 64; 41%), intermediate-risk (BDLow\/TILLow or BDHigh\/TILHigh; 23; 36%), and high-risk (BDHigh\/TILLow; 15; 23%) groups. Higher TME prognostic risk was associated with higher tumor grade (P = .03), lymphovascular invasion (P = .05), and MUC5AC immunopositivity (P = .02). TME prognostic risk index displayed better predictive ability for both OS (53.9 versus 46.1 versus 42.2) and RFS (24.8 versus 16.9 versus 15.3) than BD or TIL alone. In multivariate analysis, TME prognostic risk index was an independent prognosticator for OS (P = .003) and RFS (P = .03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>TME risk index in combination with BD and TIL was a stronger predictor of prognostic risk stratification than either BD or TIL alone for both OS and RFS in patients with AC. MUC5AC may modulate the interaction between tumor cells and immunity toward enhancing invasiveness in TME.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0131-oa","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:48:43Z","timestamp":1669726123000},"page":"1060-1074","source":"Crossref","is-referenced-by-count":4,"title":["Tumor Microenvironment Prognostic Risk and Its Association With MUC5AC in Ampullary Carcinoma"],"prefix":"10.5858","volume":"147","author":[{"given":"Sun-Young","family":"Jun","sequence":"first","affiliation":[{"name":"From the Department of Pathology (Jun, Kim, An), Incheon St Mary\ufffds Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"The Clinical Research Center (Lee), Incheon St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Il","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Jun, Kim, An), Incheon St Mary\ufffds Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"An","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Jun, Kim, An), Incheon St Mary\ufffds Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b01","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":"Cancers of the ampulla of Vater: demographics, morphology, and survival based on 5,625 cases from the SEER program","volume":"100","author":"Albores-Saavedra","year":"2009","journal-title":"J Surg Oncol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b02","first-page":"111","article-title":"Tumours of the small intestine and ampulla","volume-title":"WHO Classification of Tumours: Digestive System Tumours","author":"Klimstra","year":"2019","edition":"5th ed"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b03","volume-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2017","edition":"8th ed"},{"issue":"(6)","key":"2023083117041150900_i1543-2165-147-9-1060-b04","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1245\/s10434-019-07238-6","article-title":"The prognostic relevance of the new 8th edition of the Union for International Cancer Control classification of TNM staging for ampulla of Vater carcinoma","volume":"26","author":"Imamura","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"(6)","key":"2023083117041150900_i1543-2165-147-9-1060-b05","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1245\/s10434-019-07241-x","article-title":"Staging for ampullary carcinoma: is less actually more?","volume":"26","author":"Cloyd","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"(29)","key":"2023083117041150900_i1543-2165-147-9-1060-b06","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.3748\/wjg.v20.i29.10144","article-title":"Trends in incidence and management of cancer of the ampulla of Vater","volume":"20","author":"Rostain","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b07","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4081\/oncol.2019.440","article-title":"Therapeutic options for ampullary carcinomas: a review","volume":"13","author":"Regalla","year":"2019","journal-title":"Oncol Rev"},{"issue":"(11)","key":"2023083117041150900_i1543-2165-147-9-1060-b08","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1245\/s10434-007-9537-y","article-title":"Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma","volume":"14","author":"Woo","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"(10)","key":"2023083117041150900_i1543-2165-147-9-1060-b09","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/PAS.0b013e3181f0b05a","article-title":"Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas","volume":"34","author":"Ohike","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"(12)","key":"2023083117041150900_i1543-2165-147-9-1060-b10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/modpathol.2016.124","article-title":"Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases","volume":"29","author":"Reid","year":"2016","journal-title":"Mod Pathol"},{"issue":"(11)","key":"2023083117041150900_i1543-2165-147-9-1060-b11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/PAS.0b013e31826399d8","article-title":"Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"(10)","key":"2023083117041150900_i1543-2165-147-9-1060-b12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"(10)","key":"2023083117041150900_i1543-2165-147-9-1060-b13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater","volume":"31","author":"Chang","year":"2013","journal-title":"J Clin Oncol"},{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000863","article-title":"Immunohistochemical classification of ampullary carcinomas: critical reappraisal fails to confirm prognostic relevance for recently proposed panels, and highlights MUC5AC as a strong prognosticator","volume":"41","author":"Xue","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-9966-29-53","article-title":"RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells","volume":"29","author":"Yamazoe","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"issue":"(6)","key":"2023083117041150900_i1543-2165-147-9-1060-b16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/onc.2010.459","article-title":"GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin","volume":"30","author":"Inaguma","year":"2011","journal-title":"Oncogene"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol Cancer"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1078-0432.CCR-14-1686","article-title":"Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer","volume":"21","author":"Park","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"(2)","key":"2023083117041150900_i1543-2165-147-9-1060-b19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/bjc.2016.173","article-title":"The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer","volume":"115","author":"van Wyk","year":"2016","journal-title":"Br J Cancer"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2018.05.010","article-title":"Budding and tumor-infiltrating lymphocytes\u2013combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups","volume":"79","author":"Lang-Schwarz","year":"2018","journal-title":"Hum Pathol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2019.04.006","article-title":"Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival","volume":"89","author":"Lang-Schwarz","year":"2019","journal-title":"Hum Pathol"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.annonc.2020.01.011","article-title":"Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)","volume":"31","author":"Lee","year":"2020","journal-title":"Ann Oncol"},{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/PAS.0000000000001668","article-title":"Tumor microenvironmental prognostic risk in primary operable small intestinal adenocarcinoma","volume":"45","author":"Jun","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"(2)","key":"2023083117041150900_i1543-2165-147-9-1060-b24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","article-title":"Tumour budding in solid cancers","volume":"18","author":"Lugli","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b25","first-page":"157","article-title":"Tumours of the colon and rectum","volume-title":"WHO Classification of Tumours: Digestive System Tumours","author":"Nagtegaal","year":"2019","edition":"5th ed"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/cancers12082199","article-title":"Tumor budding and poorly differentiated clusters in small intestinal adenocarcinoma","volume":"12","author":"Jun","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"(1)","key":"2023083117041150900_i1543-2165-147-9-1060-b27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ajcp\/aqz136","article-title":"Prognostic significance of stromal and intraepithelial tumor-infiltrating lymphocytes in small intestinal adenocarcinoma","volume":"153","author":"Jun","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"(6)","key":"2023083117041150900_i1543-2165-147-9-1060-b28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"(9)","key":"2023083117041150900_i1543-2165-147-9-1060-b29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"issue":"(1)","key":"2023083117041150900_i1543-2165-147-9-1060-b30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","article-title":"Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features","volume":"121","author":"Karamitopoulou","year":"2019","journal-title":"Br J Cancer"},{"issue":"(3)","key":"2023083117041150900_i1543-2165-147-9-1060-b31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2559.2011.03975.x","article-title":"Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers","volume":"59","author":"Zlobec","year":"2011","journal-title":"Histopathology"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b32","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41598-020-60255-4","article-title":"The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: A systematic review and meta-analysis","volume":"10","author":"Idos","year":"2020","journal-title":"Sci Rep"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/his.14006","article-title":"Tumour budding\/T cell infiltrates in colorectal cancer: proposal of a novel combined score","volume":"76","author":"Dawson","year":"2020","journal-title":"Histopathology"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b34","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/cancers13123059","article-title":"Understanding the clinical impact of MUC5AC expression on pancreatic ductal adenocarcinoma","volume":"13","author":"Manne","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b35","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1158\/0008-5472.CAN-08-3879","article-title":"Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray","volume":"69","author":"Takikita","year":"2009","journal-title":"Cancer Res"},{"issue":"(1)","key":"2023083117041150900_i1543-2165-147-9-1060-b36","first-page":"9","article-title":"Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis","volume":"34","author":"Jinfeng","year":"2003","journal-title":"Int J Gastrointest Cancer"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1499-3872(12)60202-1","article-title":"Gastric- and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas","volume":"11","author":"Takano","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"(8)","key":"2023083117041150900_i1543-2165-147-9-1060-b38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/bjs.7107","article-title":"Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer","volume":"97","author":"Aloysius","year":"2010","journal-title":"Br J Surg"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-021-03109-2","article-title":"Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn\u2019s disease-associated small bowel carcinoma","volume":"479","author":"Arpa","year":"2021","journal-title":"Virchows Arch"},{"issue":"(4)","key":"2023083117041150900_i1543-2165-147-9-1060-b40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<596::AID-CNCR8>3.0.CO;2-H","article-title":"Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater","volume":"86","author":"Matsubayashi","year":"1999","journal-title":"Cancer"},{"issue":"(6)","key":"2023083117041150900_i1543-2165-147-9-1060-b41","first-page":"536","article-title":"Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas","volume":"444","author":"G\u00fcrb\u00fcz","year":"2004","journal-title":"Virchows Arch"},{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","article-title":"Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up","volume":"28","author":"Zhou","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"(3)","key":"2023083117041150900_i1543-2165-147-9-1060-b43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"(5)","key":"2023083117041150900_i1543-2165-147-9-1060-b44","first-page":"1157","article-title":"Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of Vater adenocarcinoma: comparison between expression patterns and histologic subtypes","volume":"15","author":"Sanada","year":"2006","journal-title":"Oncol Rep"},{"issue":"(9)","key":"2023083117041150900_i1543-2165-147-9-1060-b45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/jcp.2005.035832","article-title":"Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma","volume":"60","author":"Santini","year":"2007","journal-title":"J Clin Pathol"},{"issue":"(3)","key":"2023083117041150900_i1543-2165-147-9-1060-b46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-007-0444-1","article-title":"Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability","volume":"451","author":"Sessa","year":"2007","journal-title":"Virchows Arch"},{"issue":"(2)","key":"2023083117041150900_i1543-2165-147-9-1060-b47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00534-007-1228-3","article-title":"Does ampullary carcinoma arise from distended glands in the papilla of Vater?","volume":"15","author":"Sonoue","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"(75)","key":"2023083117041150900_i1543-2165-147-9-1060-b48","first-page":"1","article-title":"Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: correlation with tumor progression and prognosis","volume":"5","author":"Kawabata","year":"2010","journal-title":"Diagn Pathol"},{"key":"2023083117041150900_i1543-2165-147-9-1060-b49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1746-1596-6-102","article-title":"Mucins differently expressed in various ampullary adenocarcinomas","volume":"6","author":"Wang","year":"2011","journal-title":"Diagn Pathol"},{"issue":"(5)","key":"2023083117041150900_i1543-2165-147-9-1060-b50","first-page":"ec17","article-title":"Clinicopathological study of carcinoma of the ampulla of Vater with special reference to MUC1, MUC2 and MUC5AC expression","volume":"11","author":"Kulkarni","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"(11)","key":"2023083117041150900_i1543-2165-147-9-1060-b51","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/jclinpath-2019-205912","article-title":"Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas","volume":"72","author":"Harthimmer","year":"2019","journal-title":"J Clin Pathol"},{"issue":"(44)","key":"2023083117041150900_i1543-2165-147-9-1060-b52","doi-asserted-by":"crossref","first-page":"e17711","DOI":"10.1097\/MD.0000000000017711","article-title":"Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer","volume":"98","author":"Park","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"(7)","key":"2023083117041150900_i1543-2165-147-9-1060-b53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-019-0415-8","article-title":"Can we classify ampullary tumours better?: clinical, pathological and molecular features: results of an AGEO study","volume":"120","author":"Perkins","year":"2019","journal-title":"Br J Cancer"},{"issue":"(3)","key":"2023083117041150900_i1543-2165-147-9-1060-b54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/ijo.2013.1760","article-title":"MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways","volume":"42","author":"Hoshi","year":"2013","journal-title":"Int J Oncol"},{"issue":"(3)","key":"2023083117041150900_i1543-2165-147-9-1060-b55","first-page":"619","article-title":"Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer","volume":"38","author":"Hoshi","year":"2011","journal-title":"Int J Oncol"},{"issue":"(1)","key":"2023083117041150900_i1543-2165-147-9-1060-b56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2021.09.017","article-title":"MUC5AC serves as the nexus for beta-catenin\/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance","volume":"162","author":"Ganguly","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/9\/1060\/3256848\/i1543-2165-147-9-1060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/9\/1060\/3256848\/i1543-2165-147-9-1060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:58Z","timestamp":1764790798000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/147\/9\/article-p1060.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,11,29]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0131-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}